WCN26-9373 Adjuvant Chemotherapy and Survival Across Major Cancers: CKD-Stratified Associations in a Target-Trial Emulation

Read full text Summarise with VIRAT
Authors: Taisuke Ishii, Takahiro Higashi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

With population aging, chronic kidney disease (CKD) is increasingly common among cancer patients. Real-world evidence on the effectiveness of adjuvant chemotherapy (AC) and the appropriateness of standard regimens in CKD remains limited. We previously showed that AC use in CKD was associated with better survival. This study evaluated (1) whether the association between AC and survival is modified by CKD, and (2) among AC recipients, whether the benefit of standard regimens differs by CKD status.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Global Cancer Incidence and Screening Breast Cancer Treatment Studies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104179–104179
Publication date
25 March 2026
Language
EN